Peptides get their regulatory close-up

A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides. The meeting marks a regulatory close-up for peptides, which have gained attention in wellness circles.